Gland Pharma Limited

NSE:GLAND BSE:GLAND

HealthcarePharmaceuticals & BiotechnologyNIFTY SMALLCAP 50 +7

₹2,874.4

-0.86%1 Oct close

Mkt cap

₹47,428 Cr

Watch Alert Compare

Quarterly Annual

Year ends (Mar) · % of equity

Holder (%)	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	58%	57.86%	57.86%	51.83%	51.83%
	0%	4.33%	3.59%	6.9%	7.3%
	0%	23.23%	25.23%	33.27%	33.35%
Government	0%	0%	0%	0%	0%
	42%	14.58%	13.32%	8%	7.52%
No. of shareholders	—	—	—	—	91,500

1 disclosure

Person	Deal	Shares	Value	Holding	Filed
A. JAYATHEERTHAEmployees/Designated Employees	SellMarket Sale	191	₹3.8 L	0.00% → 0.00%	29 Sept 20257(2)

Disclosed under SEBI’s insider-trading regulations, which require a filing only above ₹10 lakh in a quarter — smaller dealings are in no disclosure. Holdings are the filer’s own percentages, not recomputed.

43 deals · 2 Sept 2021 – 17 Sept 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
17 Sept 2026	BOFA SECURITIES EUROPE SA	Block	NSE	Buy	1,50,000	₹2,826.60	₹42.40 Cr
17 Sept 2026	NORTH ROCK SG VCC	Block	NSE	Sell	1,50,000	₹2,826.60	₹42.40 Cr
4 Sept 2026	FOSUN PHARMA INDUSTRIAL PTE. LTD.	Bulk	BSE	Sell	76,05,500	₹2,827.38	₹2,150.36 Cr
4 Sept 2026	KOTAK MAHINDRA MUTUAL FUND	Bulk	BSE	Buy	27,93,000	₹2,826.60	₹789.47 Cr
4 Sept 2026	KOTAK MAHINDRA MUTUAL FUND	Block	BSE	Buy	27,93,000	₹2,826.60	₹789.47 Cr
4 Sept 2026	FOSUN PHARMA INDUSTRIAL PTE. LTD.	Block	BSE	Sell	27,93,000	₹2,826.60	₹789.47 Cr
4 Sept 2026	FOSUN PHARMA INDUSTRIAL PTE. LTD.	Bulk	BSE	Sell	22,91,500	₹2,833.45	₹649.29 Cr
4 Sept 2026	AXIS MUTUAL FUND	Block	BSE	Buy	13,57,000	₹2,826.60	₹383.57 Cr
4 Sept 2026	AXIS MUTUAL FUND	Bulk	BSE	Buy	13,57,000	₹2,826.60	₹383.57 Cr
4 Sept 2026	FOSUN PHARMA INDUSTRIAL PTE. LTD.	Block	BSE	Sell	13,57,000	₹2,826.60	₹383.57 Cr

1–10 of 43

1 / 5

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Srinivas SaduExecutive Director-Chairperson
Mr. UDO JAHANNES VETTERNon-Executive - Independent Director
Mr. Essaji Goolam VahanvatiNon-Executive - Independent Director
Ms. Naina Lal KidwaiNon-Executive - Independent Director
Mr. Jia Ai ZhangNon-Executive - Non Independent Director
Mr. Wenjie ZhangNon-Executive - Non Independent Director
Ms. Wei HuangNon-Executive - Non Independent Director
Mr. William Robert KellerNon-Executive - Independent Director
Sampath Kumar PallerlamudiCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Gland Pharma Limited

Annual record

Insider dealing

Bulk & block deals

Board and management